Zhejiang Hengkang Pharmaceutical Co., Ltd. continues to strengthen its position as a leading manufacturer within the global active pharmaceutical ingredient industry, attracting growing attention for ...

Opportunities in the pharmaceutical API manufacturing market include leveraging rising demand for complex biologics, ...

Drug makers are going beyond continuous improvement and green chemistry to increase the sustainability of small-molecule manufacturing. In the latest Intergovernmental Panel on Climate Change report ...

The Global API market is expanding due to rising chronic diseases, demand for generics post-patent expirations, and R&D ...

India’s Torrent Pharma, which has been beefing up its international focused production capabilities, is buying an API operation from another Indian player. The Ahmedabad-based drugmaker today reported ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...

Producing active pharmaceutical ingredients (API), raw materials of medicine, is urgent to save the country’s promising pharmaceuticals industry still heavily dependent on imports, industry insiders ...

Saneca Pharma is making significant investment in its API capabilities to support client demand for smaller batch sizes and streamlined scale-up. Slovakia-based CDMO Saneca Pharma announced that it is ...

Indian drugmaker Mankind Pharma intends to add an active pharmaceutical ingredient (API) manufacturing facility to its network of 16 production plants in India. The company says it will invest about ...

U.S. Ibuprofen API Market to Reach USD 0.22 Billion by 2035 Driven by Rising OTC Pain Medication DemandAustin, May 06, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Ibuprofen API Market size ...

ST Pharm, a specialized contract development and manufacturing organization (CDMO) subsidiary of Dong-A Socio Holdings, said on the 16th that it signed a contract to supply active pharmaceutical ...